APOE and systemic lupus erythematosus: Subsequently, it was demonstrated that global heterozygous deficiency of IRF5 also reduces disease in the Lyn-deficient mouse lupus model, the gld.apoE-deficient mouse lupus model, and in the Swap70-deficient Def6-deficient mouse lupus model (10, 28, 29).